4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-063367
Chief Commercial Officer gave up 288 shares (to pay taxes)
- Chief Commercial Officer acquired 1,013 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fair Brett Chief Commercial Officer | 2018-12-15 | Option exercise | +1,013 | 7,051 | D | ||
| Fair Brett Chief Commercial Officer | 2018-12-15 | Shares withheld for taxes | −288 | $7.31 | $2,105 | 6,763 | D |
| Derivatives | |||||||
| Fair Brett Chief Commercial Officer | 2018-12-15 | Option exercise · Restricted Stock Units | −1,013 | 2,025 | D | ||
Loading xslF345X03/doc4.xml…